Published 2 days ago • loading... • Updated 10 hours ago

Pharmaceutical industry criticizes the drug pricing plan Trump says he’ll sign

President Donald Trump announced plans to sign an executive order on Monday instituting a 'most favored nation' drug pricing policy in the U.S.
The policy aims to tie Medicare Part B drug prices to the lowest prices paid by other countries, reversing a blocked 2020 effort and responding to longstanding concerns about high U.S. Drug costs.
The policy is expected to affect medications administered in doctors' offices and could cut billions from Medicare, but critics warn it might not help patients and could reduce domestic pharmaceutical investment.
Stephen J. Ubl, PhRMA CEO, called the proposal a 'bad deal' that risks giving foreign governments the 'upper hand' and increasing U.S. Dependence on China for innovative medicines.
If implemented, the order could generate government savings but may not lower costs for many Americans, reflecting ongoing political and legal challenges around drug price reforms.

Insights by Ground AI

Does this summary seem wrong?

36 Articles

All

Left

Center

Right

n-tv.de

Lean Right

Price limit for drugs: US pharmaceutical industry not only threatens massive loss of sales

US President Trump plans to drastically reduce drug prices. The pharmaceutical industry is sounding the alarm and warning against serious consequences for research and supply.

14 hours ago

Read Full Article

Politiken

Lean Left

Analyst: Trump's decree is better than feared

After Trump used Novo Nordisk drugs as an example of why drug prices need to come down on Monday, the stock fell. Now more information has emerged that is causing investors to breathe a sigh of relief.

15 hours ago·Copenhagen, Denmark

Read Full Article

Spiegel

Lean Left

US intervention in drug prices scares the pharmaceutical industry

Europe is »unpredictable as China« in negotiations on drug prices,« says Donald Trump and wants to drastically reduce drugs in his country. According to manufacturers, however, it threatens medical progress.

21 hours ago·Germany

Read Full Article

South China Morning Post

Center

Big Chinese pharma can beat Trump’s policies with cost efficiencies: analysts

Trump seeks to slash domestic drug prices, bring back pharmaceutical manufacturing to the US and slap tariffs on imports.

1 day ago·Hong Kong

Read Full Article

NBC News

Lean Left

Pharmaceutical industry ‘pushing back’ against Trump executive order to lower drug prices

NBC News Health and Medical Reporter Berkely Lovelace Jr. explains President Trump’s executive order on the 30 day deadline for drugmakers to lower the cost of prescription medications.

1 day ago·United States

Read Full Article